跳至主要内容
临床试验/EUCTR2017-002712-14-DK
EUCTR2017-002712-14-DK进行中(未招募)1 期

Phase II: 68Ga-NODAGA-E[c(RGDyK)]2 Angiogenese PET for imaging angiogenesis in ischaemic heart disease

Rigshospitalet, Department of Physiology, Nuclear Medicine and PET0 个研究点目标入组 50 人开始时间: 2017年7月6日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • The inclusion criteria are patients diagnosed with chronic occlusion of the coronary being treated with Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft(CABG) operation. The patients must be above the age of 18 years, and must be capable of understanding and giving full informed written consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 25
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 25

排除标准

  • The principal exclusion criteria are:
  • 1. Patient who prior underwent cardiac surgery
  • 2. Patient recieving anti-angiogenetick treatment
  • 3. Patient with known allergi towards interveneous contrast
  • 4. Patient with pacemaker, cochlear implant or insulinpump
  • 5. Pregnancy
  • 6. Lactation
  • 7. Obesity (weight above 140 kg)
  • 8. Claustrophobia
  • 9. Re-operation after intervention
  • 10. Conversion to open surgery during intervention

研究者

发起方
Rigshospitalet, Department of Physiology, Nuclear Medicine and PET

相似试验